Patented Products Clause Samples
POPULAR SAMPLE Copied 1 times
Patented Products. For each Product the manufacture, use or sale of which for applications within the Field is covered by a Program Patent, Merck Patent or Tularik Patent, royalties shall be payable in a country until the later of (i) seven (7) years from the first commercial sale of the Product in such country, or (ii) the expiration of the last to expire Program Patent, Merck Patent or Tularik Patent covering such manufacture, use or sale.
Patented Products. If a Licensed Product is sold in a country where such Licensed Product is covered by an Enforceable Claim of the Patent Rights, then one hundred percent (100%) of the Net Sales of such Product in such country shall be used to determine the Royalty under subsection (c).
Patented Products. SANKYO shall pay a royalty at the rate of ** of the NET SALES of each Product (2/3 of which shall be for the account of OSI and 1/3 of which shall be for the account of MRC CC), the manufacture, use, or sale of ----------------------- ** This portion redacted pursuant to a request for confidential treatment. -33- 35 which is covered by a Valid Claim of the Patent Rights. In the event that OSI's contribution is limited to preparation of assay systems for screening, the royalty rate payable from SANKYO shall be ** of the NET SALES of each Product (2/3 of which shall be for the account of OSI and 1/3 of which shall be for the account of MRC CC). With respect to each Product, SANKYO shall continue to pay such royalty on the sales of such Product in each country until the expiration of the last Valid Claim under the Patent Rights applicable to such Product expires in such country.
Patented Products. Amgen will pay to Progenitor a Royalty on cumulative annual worldwide Net Sales by Amgen, its Affiliates and sublicensees of products, the making, using, selling or importing of which would, but for the licenses to the Licensed Patents granted to Amgen by Progenitor herein, infringe one or more valid, issued claims included within the Licensed Receptor Patents in the country of sale ("Patented Products") as set forth below. - Net Sales of less than or equal to [***][***] of Net Sales - Net Sales greater than [***][***] of Net Sales
Patented Products. For each Product the manufacture, use or sale of which for applications within the Field is covered by a Program Patent, Merck Patent or Tularik Patent, royalties shall be payable in a country until the later of (i) [ * ] from the first commercial sale of the Product in such country, or [ * ].